B6.Cg-B2mtm1Unc Cd3etm1Mal H2-K1b-tm1Bpe H2-D1b-tm1Bpe/Orl

Status

Available to order

EMMA IDEM:00754
International strain nameB6.Cg-B2mtm1Unc Cd3etm1Mal H2-K1b-tm1Bpe H2-D1b-tm1Bpe/Orl
Alternative nameTetraKO - CD3- and MHC class I-
Strain typeTargeted Mutant Strains : Knock-out
Allele/Transgene symbolCd3etm1Mal, B2mtm1Unc, H2-D1b-tm1Bpe, H2-K1b-tm1Bpe
Gene/Transgene symbolCd3e, B2m, H2-D1, H2-K1

Information from provider

ProviderAntonio Freitas
Provider affiliationInstitut Pasteur
Genetic informationInactivation of the Cd3epsilon gene. Inactivation of the b allele of both D and K loci of the MHC class I molecules. Inactivation of the beta2-microglobulin gene.
Phenotypic informationLack of T lymphocytes and MHC class I molecules.
ReferencesNone available
Homozygous fertileyes
Homozygous viableyes
Immunocompromisedyes

Information from EMMA

Archiving centreInstitut de Transgenose, INTRAGENE, Orléans, France
Animals used for archivinghomozygous 0, wild-type 0
Stage of embryos2-cell

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • preweaning lethality, incomplete penetrance / IMPC
  • preweaning lethality, complete penetrance / IMPC
  • small superior vagus ganglion / IMPC
  • embryonic lethality prior to tooth bud stage / IMPC
  • abnormal skin morphology / IMPC
  • hydrometra / IMPC
  • increased circulating phosphate level / IMPC
MGI phenotypes (allele matching)
  • decreased level of surface class I molecules / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • decreased IgG level / MGI
  • abnormal pancreas morphology / MGI
  • decreased susceptibility to bacterial infection / MGI
  • increased IgM level / MGI
  • decreased susceptibility to autoimmune diabetes / MGI
  • decreased circulating serum albumin level / MGI
  • increased T-helper 1 cell number / MGI
  • abnormal interleukin level / MGI
  • abnormal tumor necrosis factor level / MGI
  • increased susceptibility to infection induced morbidity/mortality / MGI
  • absent CD8-positive, alpha-beta T cells / MGI
  • abnormal pancreatic beta cell morphology / MGI
  • abnormal T cell number / MGI
  • insulitis / MGI
  • arrested T cell differentiation / MGI
  • abnormal double-negative T cell morphology / MGI
  • abnormal B cell morphology / MGI
  • abnormal regulatory T cell physiology / MGI
  • absent T cells / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • absent CD4-positive, alpha beta T cells / MGI
MGI phenotypes (gene matching)
  • absent CD8-positive, alpha-beta T cells / MGI
  • decreased IgG level / MGI
  • decreased level of surface class I molecules / MGI
  • abnormal pancreas morphology / MGI
  • decreased susceptibility to bacterial infection / MGI
  • abnormal CD8-positive, alpha-beta cytotoxic T cell morphology / MGI
  • increased IgM level / MGI
  • insulitis / MGI
  • abnormal lateral geniculate nucleus morphology / MGI
  • decreased susceptibility to autoimmune diabetes / MGI
  • decreased susceptibility to parasitic infection / MGI
  • abnormal cytotoxic T cell physiology / MGI
  • abnormal pancreatic beta cell morphology / MGI
  • decreased circulating serum albumin level / MGI
  • hemochromatosis / MGI
  • abnormal T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI
  • increased T-helper 1 cell number / MGI
  • increased gamma-delta T cell number / MGI
  • increased gamma-delta intraepithelial T cell number / MGI
  • increased tumor necrosis factor secretion / MGI
  • increased interleukin-3 secretion / MGI
  • decreased interleukin-4 secretion / MGI
  • abnormal interleukin level / MGI
  • abnormal tumor necrosis factor level / MGI
  • increased susceptibility to infection induced morbidity/mortality / MGI
  • abnormal thymus morphology / MGI
  • small thymus / MGI
  • absent CD8-positive, alpha-beta T cells / MGI
  • thymus hypoplasia / MGI
  • arrested T cell differentiation / MGI
  • seizures / MGI
  • abnormal T cell differentiation / MGI
  • abnormal double-negative T cell morphology / MGI
  • abnormal double-positive T cell morphology / MGI
  • absent CD4-positive, alpha beta T cells / MGI
  • abnormal class switch recombination / MGI
  • abnormal B cell morphology / MGI
  • abnormal regulatory T cell physiology / MGI
  • increased double-negative T cell number / MGI
  • decreased double-positive T cell number / MGI
  • abnormal T cell number / MGI
  • increased T cell apoptosis / MGI
  • abnormal T cell morphology / MGI
  • absent T cells / MGI
  • increased sensitivity to induced morbidity/mortality / MGI
  • increased DN3 thymocyte number / MGI
  • demyelination / MGI
  • abnormal immune system physiology / MGI
  • abnormal T cell activation / MGI
  • no phenotypic analysis / MGI
  • decreased susceptibility to autoimmune diabetes / MGI
  • CNS inflammation / MGI
  • abnormal immune system physiology / MGI
  • decreased susceptibility to autoimmune diabetes / MGI
  • increased CD4-positive, alpha beta T cell number / MGI
  • decreased CD8-positive, alpha-beta T cell number / MGI

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen embryos. Delivered in 4 weeks (after paperwork in place). €1740*

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Genotyping protocol

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
For this strain no provider MTA is needed. Distribution is based on the EMMA conditions only.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).